CCL20 and colorectal carcinoma: It has been shown to hinder the body’s natural ability to fight against tumors by attracting two types of immune cells known as TAMs and MDSC to the TME.105 Xu et al. found that high levels of F. nucleatum in CRC tissues are often accompanied by high levels of CCL20 expression.